Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Globus Medical Q2 2024 Adj. EPS $0.75 Beats $0.68 Estimate, Sales $629.700M Beat $615.345M Estimate

Author: Benzinga Newsdesk | August 06, 2024 04:16pm
Globus Medical (NYSE:GMED) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.68 by 10.29 percent. The company reported quarterly sales of $629.700 million which beat the analyst consensus estimate of $615.345 million by 2.33 percent. This is a 115.94 percent increase over sales of $291.615 million the same period last year.

Posted In: GMED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist